ESC Congress - Results of the European Infective Endocarditis registry (ESC-EORP EURO-ENDO)
With Thomas F. Lüscher, University Zurich - Switzerland & Stephan Windecker, Swiss Cardiovascular Center Bern - Switzerland Link to paper
4 Syys 20199min
ESC Congress 2019 - Is perivascular fat a new cardiovascular risk factor? Results of SCOT-HEART
With Stephan Achenbach, University of Erlangen - Germany & Victoria Delgado, Leiden University Medical Center - Netherlands.
4 Syys 20199min
ESC Congress 2019 - DANAMI-2 - 16-year follow-up of the Danish Acute Myocardial Infarction 2 trial - Primary percutaneous coronary intervention versus fibrinolysis in ST-elevation myocardial infarction
With Borja Ibanez, Spanish National Centre for Cardiovascular Research - Spain & Allan Davies, Hunter New England Health - Australia.
3 Syys 20197min
ESC Congress 2019 - Residual Inflammatory Risk Associated with Interleukin-18 and Interleukin-6
With Thomas F. Lüscher, University Zurich - Switzerland, Filippo Crea & Luigi Biasucci, Catholic University of the Sacred Heart - Italy. Link to paper
3 Syys 201911min
ESC Congress 2019 - The relation between systemic inflammation and incident cancer in patients with stable cardiovascular disease, a cohort study
With Peter Libby & Paul Ridker, Brigham and Women's Hospital, Harvard Medical School - USA. Link to paper
2 Syys 201913min
ESC Congress 2019 - Estimating individual lifetime benefit and bleeding risk of adding rivaroxaban to aspirin for patients with stable cardiovascular disease: results from the COMPASS trial
With Roxana Mehran, The Mount Sinai Hospital - USA, Jan Steffel, University Hospital Zurich - Switzerland & Diana Gorog, University of Hertfordshire - UK Link to paper:
2 Syys 20199min
ESC Congress 2019 - High penetrance and similar disease progression in probands and in family members with arrhythmogenic cardiomyopathy
With Perry Elliott, University College, London - UK & Benjamin Meder, University of Heidelberg - Germany. Link to paper
1 Syys 201914min
ESC Congress 2019 - Relationship between hypoglycaemia, outcomes and empagliflozin treatment effect in EMPA-REG OUTCOME
With Eberhard Standl, Helmholtz Centre - Germany & Anna Norhammar, Karolinska Institutet - Sweden. Link to paper
1 Syys 201913min
